1. Home
  2. CDNA vs VRTS Comparison

CDNA vs VRTS Comparison

Compare CDNA & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$144.11

Market Cap

968.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
VRTS
Founded
1998
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
968.0M
IPO Year
2007
1995

Fundamental Metrics

Financial Performance
Metric
CDNA
VRTS
Price
$21.60
$144.11
Analyst Decision
Buy
Hold
Analyst Count
6
4
Target Price
$28.00
$158.00
AVG Volume (30 Days)
652.5K
73.4K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
6.68%
EPS Growth
N/A
18.24
EPS
0.05
1.05
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
N/A
Revenue Next Year
$11.31
$1.66
P/E Ratio
$429.80
$134.82
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$121.61
52 Week High
$23.24
$214.88

Technical Indicators

Market Signals
Indicator
CDNA
VRTS
Relative Strength Index (RSI) 59.06 55.56
Support Level $15.80 $135.82
Resistance Level $22.89 $147.15
Average True Range (ATR) 1.00 5.32
MACD -0.06 -0.18
Stochastic Oscillator 76.54 79.01

Price Performance

Historical Comparison
CDNA
VRTS

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

Share on Social Networks: